trial

A Definitive Estrogen Patch Study (ADEPT)

NCTId NCT00357006
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 180 (actual)
Sponsored by The Alfred
Primary completion 2011-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
180 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2006-07
Primary completion
2011-10
Eligibility
FEMALE · 18 Years · 50 Years

Interventions & indications

Drugs
Estradiol

Sponsors

The AlfredLead Sponsor
Stanley Medical Research InstituteCollaborator

Investigators

1
Jayashri Kulkarni, MBBS, MPM, FRANZCP, PHDPrincipal Investigator

Sites

1 total
Melbourne, Australia

Linked catalysts

1
A Definitive Estrogen Patch Study (ADEPT) — primary completion2011-10

Facts & assertions

4 sourced
Enrollment
180
Phase
PHASE2
Primary Completion Date
2011-10
Status
COMPLETED
relationships
The graph out of here
drug
Estradiol
drug
lead_sponsor
The Alfred
company
collaborator
Stanley Medical Research Institute
company
indication
Schizophreniform Disorder(Not in Manic Phase)
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Jayashri Kulkarni, MBBS, MPM, FRANZCP, PHD
person